$CLRI Cashflow Statement | Understand Stock

$CLRI

$0.01 +$0.00 (59.32%) Close

$CLRI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flow

In USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
NET LOSS
Cash Flows From Operating Activities
Depreciation expense
Gain on forgiveness of PPP loan
Gain on the settlement and reversal of accounts payable
Adjustments to reconcile net income to net cash used in operating activities:
Amortization of ReadyOp software platform
Depreciation and amortization expense
Amortization of operating lease - right-of-use asset
Gain on the settlement and reversal of accounts payable
Gain on the settlement of accounts payable
Gain on settlement of accounts payable
Provision for credit losses
Impairment of intangible asset
Loss on sale of fixed asset
Note and interest receivable - related party write off(Increase)decrease in assets:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Due from related party

Increase (decrease) in liabilities:
Note and interest receivable - related party write off
Accounts payable
Accrued expenses
Deferred revenue
Operating lease liability

Net Cash Provided by Operating Activities
Cash Flows From Investing Activities
Purchase of fixed assets
Purchase of intangible assets
Purchase of intangible asset - customer list
Net Cash Used in Investing Activities
Repayment of notes payable stockholders
Cash Flows From Financing Activities
Net increase in cash
Cash at beginning of year
Cash at end of year
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
Cash paid for taxes
Return of 875,000 shares of common stock in exchange for notes and interest receivable
Supplemental disclosure of non-cash investing and financing activities:
Return of 875,000 shares of common stock in exchange for notes and interest receivable
Cancellation of 458,300 shares of common stock
Series C Convertible Preferred shares exchanged for common stock
Operating lease right of use asset recorded on adoption of ASC 842
Right-of-use asset obtained in exchange for operating lease liability
Prior period adjustment

Comments